EB Research Partnership
Overview
EB Research Partnership is a non-profit investment firm that utilizes a venture philanthropy model to fund research and development of treatments and cures for Epidermolysis Bullosa (EB) and other rare diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Castle Creek Biosciences | Dec 2018 | Private Placement | Co-investor |
| Immusoft | Nov 2016 | Series A | Co-investor |
| Kamal Therapeutics, Inc. | Dec 2019 | Seed | Co-investor |
| Nova Anchora | Nov 2026 | Early Funding | Co-investor |
| Constant Therapeutics | Feb 2019 | Grant | Co-investor |
Key People
Jamie Silver
Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is EB Research Partnership based?
EB Research Partnership is headquartered in New York City, New York, United States.
When was EB Research Partnership founded?
EB Research Partnership was founded in 2010.
How many portfolio companies does EB Research Partnership have?
EB Research Partnership has 5 portfolio companies in Caplight's dataset.
What are some companies in EB Research Partnership's portfolio?
Portfolio companies visible on Caplight include Castle Creek Biosciences, Immusoft, Kamal Therapeutics, Inc., Nova Anchora, Constant Therapeutics.
What was EB Research Partnership's most recent investment shown here?
EB Research Partnership's most recent investment in this portfolio sample was in Nova Anchora in 2026.
What sectors does EB Research Partnership focus on?
EB Research Partnership focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does EB Research Partnership focus on?
EB Research Partnership typically invests at the Early stage.
What is EB Research Partnership's AUM?
EB Research Partnership's assets under management are estimated between $22.9M and $24.7M.